Literature DB >> 12112157

Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.

Ian A Cook1, Melinda L Morgan, Jennifer J Dunkin, Steven David, Elise Witte, Robert Lufkin, Michelle Abrams, Susan Rosenberg, Andrew F Leuchter.   

Abstract

BACKGROUND: Cortical atrophy, central atrophy, deep white-matter hyperintensities, and periventricular hyperintensities are reported in normal aging.
OBJECTIVES: We examined the effects of estrogen replacement therapy (ERT) on these forms of 'subclinical structural brain disease' (SSBD) in normal, postmenopausal women in a pilot, naturalistic, longitudinal study of 15 subjects.
METHODS: Two assessments were performed at least two years apart, with volumetric magnetic resonance imaging (MRI) and neuropsychological testing.
RESULTS: Women receiving open-label ERT showed significantly less progression of SSBD than those who did not.
CONCLUSIONS: The association between reduced SSBD progression and ERT suggests this intervention could help preserve normal brain structure in healthy elderly women. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12112157     DOI: 10.1002/gps.644

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  4 in total

Review 1.  Differential aging of the brain: patterns, cognitive correlates and modifiers.

Authors:  Naftali Raz; Karen M Rodrigue
Journal:  Neurosci Biobehav Rev       Date:  2006-08-17       Impact factor: 8.989

2.  Preliminary evidence that long-term estrogen use reduces white matter loss in aging.

Authors:  Duy M Ha; Jingang Xu; Jeri S Janowsky
Journal:  Neurobiol Aging       Date:  2006-10-09       Impact factor: 4.673

Review 3.  Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause.

Authors:  Mary Lou Voytko; Gregory Paul Tinkler; Carole Browne; Joseph R Tobin
Journal:  Am J Primatol       Date:  2009-09       Impact factor: 2.371

4.  Longitudinal assessment of global and regional rate of grey matter atrophy in 1,172 healthy older adults: modulation by sex and age.

Authors:  Fabrice Crivello; Nathalie Tzourio-Mazoyer; Christophe Tzourio; Bernard Mazoyer
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.